Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-22
DOI
10.3389/fnins.2019.00889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases
- (2019) Yusuke Seino et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer’s Disease and Subcortical Ischemic Vascular Disease: A Systematic Review
- (2019) Christina Manniche et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF and blood biomarkers for Parkinson's disease
- (2019) Lucilla Parnetti et al. LANCET NEUROLOGY
- Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study
- (2018) Brit Mollenhauer et al. JOURNAL OF NEUROCHEMISTRY
- Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease
- (2017) Claudio Liguori et al. JOURNAL OF NEUROLOGY
- α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
- (2017) Yvette C Wong et al. NATURE MEDICINE
- Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production
- (2017) Rikke H. Kofoed et al. NEUROBIOLOGY OF DISEASE
- Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
- (2017) Cristina Cariulo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice
- (2017) Mantia Karampetsou et al. Scientific Reports
- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
- (2017) Nour K. Majbour et al. Scientific Reports
- Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
- (2017) Hugo Vicente Miranda et al. Scientific Reports
- The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
- (2016) Anja Hviid Simonsen et al. Biomarkers in Medicine
- Alpha-Synuclein as a Biomarker for Parkinson's Disease
- (2016) Anzari Atik et al. BRAIN PATHOLOGY
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
- (2016) Natalie Landeck et al. Molecular Neurodegeneration
- Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
- (2016) Abid Oueslati Journal of Parkinsons Disease
- Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients
- (2015) Edward J. Wild et al. JOURNAL OF CLINICAL INVESTIGATION
- Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function
- (2015) Kerstin Buck et al. NEUROBIOLOGY OF DISEASE
- Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging
- (2015) Niklas K. U. Koehler et al. PLoS One
- Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
- (2015) Tessandra Stewart et al. Acta Neuropathologica Communications
- Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
- (2015) Ryotaro Ishii et al. PLoS One
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
- (2014) Min Shi et al. ACTA NEUROPATHOLOGICA
- A Sensitive A Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
- (2014) M. J. Savage et al. JOURNAL OF NEUROSCIENCE
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Polyglutamine- and Temperature-Dependent Conformational Rigidity in Mutant Huntingtin Revealed by Immunoassays and Circular Dichroism Spectroscopy
- (2014) Valentina Fodale et al. PLoS One
- Protein phosphorylation in neurodegeneration: friend or foe?
- (2014) Sandra Tenreiro et al. Frontiers in Molecular Neuroscience
- Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
- (2013) Adrien W. Schmid et al. MOLECULAR & CELLULAR PROTEOMICS
- Polo-like kinase 2 regulates selective autophagic -synuclein clearance and suppresses its toxicity in vivo
- (2013) A. Oueslati et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
- (2013) Penelope G. Foulds et al. Scientific Reports
- Novel One-step Immunoassays to Quantify α-Synuclein
- (2012) Michael Bidinosti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
- (2012) Ana Gorostidi et al. PLoS One
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Phosphorylation of α-Synuclein at Y125 and S129 Alters Its Metal Binding Properties: Implications for Understanding the Role of α-Synuclein in the Pathogenesis of Parkinson’s Disease and Related Disorders
- (2011) Yu Lu et al. ACS Chemical Neuroscience
- Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
- (2011) Penelope G. Foulds et al. FASEB JOURNAL
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
- (2011) P.G. Foulds et al. NEUROBIOLOGY OF DISEASE
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits -Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
- (2010) K. E. Paleologou et al. JOURNAL OF NEUROSCIENCE
- Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of α-synuclein in HEK293 cells
- (2009) Masahiro Sakamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aβ1–42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible Aβ1–42 aggregation?
- (2009) Giulia M. Sancesario et al. EXPERIMENTAL NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started